26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

VI. Iron Metabolism in Cells<br />

267<br />

induced by interleukin-6 (IL-6), IL-10, and glucocorticoids<br />

( Graversen et al ., 2002 ). The heme-hemopexin complexes<br />

undergo endocytosis after binding to CD91, also called the<br />

low-density lipoprotein receptor-related protein (LRP) or<br />

α 2 -macroglobulin receptor. Once inside the cell, the complexes<br />

are transported to lysosomes for degradation, and<br />

receptors are recycled to the cell surface ( Hvidberg et al .,<br />

2005 ).<br />

C. Iron Metabolism in Hepatocytes<br />

The liver is essential for normal iron homeostasis in the<br />

body. It regulates iron movement into and around the body<br />

through hepcidin synthesis, accounts for about 40% <strong>of</strong> the<br />

body iron stores, and is the site <strong>of</strong> synthesis <strong>of</strong> apotransferrin,<br />

ceruloplasmin, haptoglobin, and hemopexin plasma<br />

proteins ( Anderson and Frazer, 2005 ).<br />

Hepatocytes synthesize hepcidin in an endocrine manner<br />

to regulate iron metabolism in the body. Hepcidin is a small<br />

cationic peptide (25 amino acids in humans) that forms from<br />

a larger prohepcidin peptide (84 amino acids) ( Park et al .,<br />

2001 ). Hepcidin has been cloned, expressed, and sequenced<br />

in several species, including dogs ( Fry et al ., 2004 ; Verga<br />

Falzacappa and Muckenthaler, 2005 ). Because <strong>of</strong> its small<br />

size, hepcidin is rapidly cleared by the kidney and is measurable<br />

in urine. Using immunohistochemistry techniques,<br />

prohepcidin is localized to organelles <strong>of</strong> the secretory pathway,<br />

particularly the Golgi apparatus, <strong>of</strong> hepatocytes suggesting<br />

that molecules may accumulate before receiving<br />

a signal for secretion ( Wallace et al ., 2005 ). Prohepcidin<br />

circulates in plasma, but its plasma concentration does not<br />

correlate well with urinary hepcidin concentrations or other<br />

iron parameters ( Kemna et al ., 2005 ). The site, nature, and<br />

potential regulation <strong>of</strong> the conversion <strong>of</strong> prohepcidin to hepcidin<br />

remain to be identified.<br />

A number <strong>of</strong> systemic stimuli, including body iron<br />

stores, anemia, hypoxia, degree <strong>of</strong> erythropoiesis, and<br />

inflammation have been reported to modulate hepcidin<br />

levels; however, the pathways involved in hepcidin production<br />

remain to be elucidated ( Anderson and Frazer, 2005 ;<br />

Steele et al ., 2005 ). Anemia, hypoxia, and erythropoietin<br />

themselves do not seem to be <strong>of</strong> primary importance ( Pak<br />

et al ., 2006 ; Vokurka et al ., 2006 ). Hepcidin production is<br />

modulated by body iron requirements, which are largely<br />

influenced by the magnitude <strong>of</strong> erythropoiesis present<br />

( Wilkins et al ., 2006 ). A signal arising from erythropoietic<br />

activity in bone marrow is proposed to regulate hepcidin<br />

production, but its nature is unknown at the time <strong>of</strong><br />

this manuscript preparation ( Pak et al ., 2006 ). The content<br />

<strong>of</strong> diferric transferrin in plasma may be a key indicator <strong>of</strong><br />

body iron requirement ( Wilkins et al ., 2006 ). Many questions<br />

remain concerning how hepcidin expression is modulated<br />

in response to body iron requirements; however,<br />

three molecules (hemochromatosis [HFE] protein, TfR2,<br />

and hemojuvelin) have been identified that are involved in<br />

the regulation <strong>of</strong> this pathway(s). Defects in each <strong>of</strong> these<br />

molecules in humans or mice have resulted in inappropriately<br />

low hepcidin levels and increased iron absorption<br />

leading to hemochromatosis. It is hypothesized that hepcidin<br />

is regulated by HFE and TfR2 on hepatocyte surfaces<br />

in response to plasma transferrin saturation. TfR2 has a<br />

25-fold lower affinity for diferric transferrin than does<br />

TfR1 and would presumably become active when diferric<br />

transferrin concentrations are high ( Anderson and Frazer,<br />

2005 ). The pathway involving plasma diferric transferrin<br />

concentration may not be the only way hepcidin production<br />

is regulated. Hemojuvelin may modulate this pathway<br />

or affect hepcidin synthesis independently ( Steele et al .,<br />

2005 ). Studies indicate that hepcidin synthesis is stimulated<br />

by certain bone morphogenetic proteins (BMPs)<br />

that bind to hemojuvelin, regulating hepcidin expression<br />

through a BMP signal transduction pathway ( Truksa et<br />

al ., 2006 ). In addition, hepcidin expression increases in<br />

response to inflammation, and this increase precedes any<br />

alteration in transferrin saturation ( Steele et al ., 2005 ).<br />

Most <strong>of</strong> the iron stored within the liver is found in<br />

hepatocytes stored as ferritin. Hepatocytes secrete a glycosylated<br />

form <strong>of</strong> ferritin into plasma ( Ghosh et al ., 2004 ).<br />

Ferritin in human plasma is primarily composed <strong>of</strong> L subunits,<br />

but H subunits predominate in ferritin in dog plasma<br />

( Watanabe et al ., 2000 ). Plasma ferritin concentrations<br />

generally correlate with body iron stores; however, ferritin<br />

is an acute phase protein that increases in plasma during<br />

inflammation ( Torti and Torti, 2002 ).<br />

Hepatocyte membranes contain ferritin receptors.<br />

However, serum ferritin is present in low concentrations and<br />

contains little iron, so it is unlikely that hepatocytes take up<br />

significant amounts <strong>of</strong> iron from plasma by this mechanism<br />

under normal conditions ( Anderson and Frazer, 2005 ; Ponka<br />

et al ., 1998 ). Like other cells, hepatocytes utilize TfR1<br />

to transport iron into the cells. NTBI is thought to be chelated<br />

by small organic acids, such as citrate, but some may<br />

be bound loosely to proteins such as albumin ( Anderson and<br />

Frazer, 2005 ). The liver rapidly clears NTBI. In experimental<br />

studies using mice, the half-time <strong>of</strong> clearance <strong>of</strong> NTBI<br />

in plasma was 30 sec, compared to a half-time clearance<br />

for transferrin-bound iron <strong>of</strong> 50 min (Craven et al ., 1987 ).<br />

Like macrophages and enterocytes, hepatocytes utilize<br />

ferroportin to export iron to plasma. Ferroportin expression<br />

is lower in hepatocytes than in enterocytes and<br />

macrophages, which may help explain why these cells preferentially<br />

accumulate iron in most iron-overload conditions<br />

(Rivera et al ., 2005 ).<br />

As discussed earlier, transferrin (apotransferrin with<br />

bound Fe 3 ions) is critical for normal iron transport to cells.<br />

Liver synthesis and release <strong>of</strong> apotransferrin to plasma is<br />

increased in most species in response to iron deficiency (but<br />

not generally in dogs) and decreased in response to inflammation<br />

(negative acute phase protein). Transferrin deficient

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!